» Articles » PMID: 31153878

Examining Weight Suppression As a Transdiagnostic Factor Influencing Illness Trajectory in Bulimic Eating Disorders

Overview
Journal Physiol Behav
Date 2019 Jun 3
PMID 31153878
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Recent research indicates that weight suppression (WS: defined as the difference between highest lifetime and current weight) prospectively predicts illness trajectory across eating disorders characterized by binge eating, including AN binge-purge subtype (ANbp), bulimia nervosa (BN), and binge eating disorder (BED), collectively referred to as bulimic eating disorders. Through a series of studies, we have developed a model to explain the link between WS and illness trajectory in bulimic eating disorders. Our model posits that WS contributes to reduced circulating leptin, which leads to reduced postprandial glucagon-like peptide 1 (GLP-1) response. Diminished leptin and GLP-1 function contribute to alterations in two reward-related constructs in the Research Domain Criteria (RDoC): reward value/effort and reward satiation. Respectively, these changes increase drive/motivation to consume food and decrease ability for food consumption to lead to a state of satiation/satisfaction. Combined, these alterations increase risk for experiencing large, out-of-control binge-eating episodes. The following review presents evidence that contributed to the development of this model as well as preliminary findings from an on-going project funded to test this model.

Citing Articles

Understanding Bone Density Loss in Eating Disorders: Contributions of Weight Suppression and Speed of Weight Loss.

Todisco P, Meneguzzo P J Clin Med. 2025; 13(24.

PMID: 39768458 PMC: 11728306. DOI: 10.3390/jcm13247537.


A novel weight suppression score associates with distinct eating disorder and ultra-processed food symptoms compared to the traditional weight suppression measure among adults seeking outpatient nutrition counseling.

Wiss D, LaFata E, Tomiyama A J Eat Disord. 2024; 12(1):75.

PMID: 38853271 PMC: 11162565. DOI: 10.1186/s40337-024-01029-5.


Elevated interleukin-6 in women with binge-eating spectrum disorders.

Campanile A, Eckel L, Keel P Int J Eat Disord. 2024; 57(7):1510-1517.

PMID: 38445571 PMC: 11262979. DOI: 10.1002/eat.24183.


The role of sexual assault history and PTSD in responses to food intake among women with bulimic-spectrum eating disorders.

Hill N, Abber S, Keel P Eat Disord. 2023; 32(3):266-282.

PMID: 38093449 PMC: 11116069. DOI: 10.1080/10640266.2023.2293597.


Weight Suppression and Risk for Childhood Psychiatric Disorders.

Sim L, Whiteside S, Harbeck-Weber C, Sawchuk N, Lebow J Child Psychiatry Hum Dev. 2023; .

PMID: 37853282 DOI: 10.1007/s10578-023-01617-7.


References
1.
Roehrig M, Masheb R, White M, Grilo C . Dieting frequency in obese patients with binge eating disorder: behavioral and metabolic correlates. Obesity (Silver Spring). 2009; 17(4):689-97. PMC: 3678720. DOI: 10.1038/oby.2008.600. View

2.
Stice E, Durant S, Burger K, Schoeller D . Weight suppression and risk of future increases in body mass: effects of suppressed resting metabolic rate and energy expenditure. Am J Clin Nutr. 2011; 94(1):7-11. PMC: 3127521. DOI: 10.3945/ajcn.110.010025. View

3.
Eckert E, Pomeroy C, Raymond N, Kohler P, Thuras P, Bowers C . Leptin in anorexia nervosa. J Clin Endocrinol Metab. 1998; 83(3):791-5. DOI: 10.1210/jcem.83.3.4661. View

4.
Graham D, Erreger K, Galli A, Stanwood G . GLP-1 analog attenuates cocaine reward. Mol Psychiatry. 2012; 18(9):961-2. PMC: 3700649. DOI: 10.1038/mp.2012.141. View

5.
Brandao P, Garcia-Souza E, Neves F, Pereira M, Sichieri R, de Moura E . Leptin/adiponectin ratio in obese women with and without binge eating disorder. Neuro Endocrinol Lett. 2010; 31(3):353-8. View